“The moral test of a government is how it treats those who are at the dawn of life, the children; those who are in the twilight of life, the aged; and those who are in the shadow of life, the sick and the needy, and the handicapped.” – Hubert Humphrey
passionate pachyderms
Pharmacist Steve steve@steveariens.com 502.938.2414
White Plains, New York – January 4th, 2022 – A new report published by PharmacyChecker entitled “Not Made in the USA” shows that 68% of the top 100 highest dollar finished drug formulations (FDFs) paid through Medicare Part D in 2018 were imported. Additionally, 78% of the active pharmaceutical ingredients (APIs) of those same 100 drugs are foreign made. Contrary to most imported generic medications, these FDA-approved brand-name drug formulations are made in high-income countries that have comparable to, if not stronger, systems of pharmaceutical manufacturing than the United States. Sixty-seven, all except one of the imported medications, were made in either the European Union, Canada, Japan, Singapore, Switzerland, or the United Kingdom. Brand Neurontin (gabapentin), was imported from India.
For reasons of drug affordability, safety, and national security, there is cause for concern among American consumers and policymakers about where prescription drugs are made. Over the last 20 years, the U.S. Government Accountability Office, academic and public policy researchers, and the media have relied on FDA data to inform the public that 80% of APIs and, for over a decade, that 40% of FDFs sold in U.S. pharmacies are imported. Those figures were never backed up with supporting data and had gone unquestioned in Congressional reports. The global pandemic has brought important discussions to the forefront about drug quality, healthcare affordability, and U.S. dependence on foreign countries for pharmaceutical supplies, all of which are addressed in “Not Made in the USA.”
“The public should know that importation is unequivocally the main artery of our drug supply chain,” stated Gabriel Levitt, primary author. “Unfortunately, not only transparency, but accuracy, is lacking about where drugs are made. The FDA does not seem to publish or even have good data for internal purposes. The industry, while simultaneously fearmongering about drug importation, relies on drug importation to sell medications at much higher prices than available in all other high-income countries. Common sense, facts, and public health need to be at the forefront of how we approach importation and prescription drug affordability moving forward.”
For its dataset, “Not Made in the USA” relied on the Medicare Part D Drug Spending Dashboard and Data. The top 100 drugs in terms of total spending were analyzed, which represented 57% of all spending in Medicare Part D for 2018. To determine the countries of origin for both FDFs and APIs, PharmacyChecker carefully reviewed prescription drug labels as found in the U.S. National Library of Medicine. While federal law under the FDA’s jurisdiction does not require drug manufacturers to publish the source country of a medication, other laws, notably the Tariff Act of 1930, do require such disclosures for imported products, including drugs. Where a pill bottle often doesn’t have this information, the actual drug manufacturer’s label usually does.
Of the 100 drugs analyzed that are accessible online, the average international mail-order prices were 75.53% lower than average U.S. pharmacy prices. Average prices available among drugs from Canadian pharmacies, specifically, were 70.18% lower than average U.S. pharmacy retail prices.
Because the pharmaceutical industry was able to stave off larger policy lifts in the Build Back Better Act, importation could become far more important in realizing a future where U.S. drug prices are comparable to the lower prices available in other high-income countries. Despite current regulatory restrictions, according to a survey by the Kaiser Family Foundation, about eight percent (20 million) of Americans have imported prescription drugs for personal use.
“Americans should have full access to wholesale and personal importation of brand name drugs and the regulatory hurdle is worth the resulting savings,” said Levitt.
About PharmacyChecker
PharmacyChecker, based in New York, is the only independent company that verifies the credentials of and accredits international online pharmacies, publishing a list of accredited online pharmacies and drug price comparisons based on those pharmacies. PharmacyChecker insight and accreditation have been recommended and/or referenced by AARP Magazine, the New York Times, the People’s Pharmacy, Yahoo Finance, and others. For more information, visit www.pharmacychecker.com.
Press Contact: Lucia Mueller, Director of Communications for PharmacyChecker.com | lucia.mueller@pharmacychecker.com | (718) 554-306
Drug companies raised the prices on hundreds of medications on Jan. 1, with most prices up 5% to 6% on average.
Why it matters: The start of the new year is the most popular time for drug companies to hike prices, and even though high drug prices remain one of the biggest political health care issues, increases in 2022 are tracking in line with other recentyears.
The number of drugs that had price increases on Jan. 1 of prior years according to 46brooklyn: 629 (2021), 385 (2020), 359 (2019), 538 (2018) and 494 (2017).
Many drugmakers implement price hikes on other days throughout January, so expect more increases in the coming days.
Between the lines: Several blockbuster drugs were included in this initial batch of 2022 price hikes.
Gilead: ⬆️ 5.6% on HIV drugs Biktarvy and Descovy.
Vertex: ⬆️ 4.9% on Trikafta, a blockbuster cystic fibrosis medication that has no competitors and already has a list price of more than $311,000 per year.
Yes, but: These actions affect the drugs’ list prices. Pharmacy benefit managers negotiate lower drug prices in the form of rebates, so drugmakers often collect lower net prices.
However, list prices still matter because they are what the uninsured pay, and deductibles and coinsurance rates are often based on a drug’s list price.
Drug companies also capture most or all of a list price increase for patented drugs that have little competition, like those mentioned above.
What they’re saying: “We expect net prices to continue to decline due to increased rebates and discounts,” a Gilead spokesperson said in response to the company’s price hikes. The spokesperson did not answer specific questions about the rebates for those drugs.
“The modest increase is necessary to support investments that allow us to continue to discover new medicines and deliver those breakthroughs to the patients who need them,” a Pfizer spokesperson said. When posed specific questions about Ibrance’s rebates, the spokesperson said: “We do not disclose detail at the product-level.”
Vertex’s price increases on Trikafta and its other cystic fibrosis drugs “are the first price increases for a Vertex medicine since 2017, and the first ever for … Trikafta, and they “reflect the significant value these medicines bring to patients.” Vertex similarly did not respond to questions about rebates.
Our thought bubble: List price increases don’t tell the entire story about U.S. drug pricing, but drug company claims about how net prices are falling right now distort how much prices have increased over time.
The above graphic shows where a “lion’s share’ of the money pay’s at the register goes… to a bunch of middleman, that produce no products and have no inventory and yet decides how much profit the pharmacy grosses and the pharma manufacturer makes. These middlemen EXTRACT discounts, rebates, kickback from the Pharma’s for putting a particular pharma med on their approved formulary – no prior authorization is needed for the pt to get the medication that their prescribers wants for the pt… It has been claimed that on some meds those $$$ could reach up to 75% of Average Wholesaler Price.. and that overall these middlemen can increase the price of the med to the pt by as much as DOUBLING IT… and all of those EXTRA DOLLARS drops into the middleman’s coffers. This all started back in the 70’s and one has to wonder how politicians/bureaucrats were convinced that having more middlemen in our healthcare system – each with their own overhead and profit goal – would/could help lower overall healthcare costs. When I first became licensed Pharmacist, none of these middlemen were around and Rxs were abt 6% of overall medical costs and today they are up in the 12% range. Even though “back in the day” we had 90%-95% brand name meds to fill Rxs and today we have about a 90% generic utilization.
NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, ESTHER HYATT PH.D., IN THE SPIRIT OF JOSEPH SOLVO ESQ., IN THE SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF PATRICIE LUMUMBA, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, SHELLEY HIGHTOWER, BS., PHARMD., LEROY BAYLOR, BEVERLY C. PRINCE FACS, MD., ADRIENNE EDMUNDSON, NATASHA DUVALL PHARMD., WALTER L. SMITH BS., LEROY BAYLOR, BS., MS., MS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
In The
Supreme Court of the United States
XIULU RUAN,
Petitioner,
v.
UNITED STATES OF AMERICA,
Respondent.
On Writ of Certiorari
to the United States Court of Appeals for the Eleventh Circuit
BRIEF AMICUS CURIAE OF PHYSICIANS AGAINST ABUSE IN SUPPORT OF PETITIONER
SEBASTIAN OHANIAN, ESQ.
IDENTITY AND INTEREST OF AMICUS CURIAE
1
Physicians Against Abuse, (“PAA”) was founded in 2019 in response to the astronomical number of convictions against physicians involving “scope of practice” charges that have sprung up in the past two decades. PAA is made up five Board Members and is a Florida Corporation in the process of gaining nonprofit status.
UNITED STATES SUPREME COURT BUILDING
Physician Board Members of PAA are uniquely situated in identifying the root cause of criminal prosecutions against physicians because either they been themselves previously subjected to criminal prosecution and/or have had exposure to the criminal court system.
Vilasini Ganesh MD 63 months Healthcare Fraud
Prior to founding the organization, the Board members conducted a review of 211 convictions against physicians over a ten-year span involving prescription and/or health care fraud.
The inescapable conclusion from review of trial transcripts, including but not limited to opening and closing statements and testimony of expert
witnesses, was that the prosecutions against physicians amounted to nothing short of ‘blind leading the blind’- where one blind is the prosecutor and the other blind is the physician’s own attorney.
____________________________________________
1 Blanket consent was provided by counsel for Petitioner. In addition, PAA sought consent from both counsel for Petitioner and Respondent. Pursuant to Rule 37.6, Amicus Curiae affirms that no counsel for any party authored this brief in whole or in part, and no counsel or party made a monetary contribution intended to fund the preparation or submission of this brief. No person other than Amicus Curiae, or its members made a monetary contribution to its preparation or submission
RENNE BARE PHARMACIST NEW CASTLE, WYOMING
2
In analyzing the root cause of the near 99% percent success rate of convictions against physicians, PAA concluded that what it all boiled down to was a prosecutor with a hunch hiring an expert using the deep pockets of the government, often not even in the same field as the accused physician, to criminalize behavior of the accused physician.
Christina Black MD, Cosmetic Surgery, Targeted an Advocate Fighter Against Physicians Abuse
While this may be acceptable in the context of medical malpractice litigation, it is not acceptable where the consequences are loss of freedom for the accused physician.
Dr. Ramana Gopalan, MD is an Internal Medicine Specialist in Catonsville, MD, and has over 37 years of experience in the medical field. He graduated from Jipmer medical school in 1984. He is affiliated with
Relying on a three pronged approach, (1) the phrase, “not for a legitimate medical purpose”, (2) hired government expert, and (3) ability to show substantial wealth for the accused physician, federal prosecutors have been successfully getting jury to return a guilty verdict in 9 out of 10 “scope of practice” cases all over the country.
This formula has made US the only country in the world mass incarcerating physicians.
This is not because all the criminal doctors miraculously reside in the United States, but rather, because there is something significantly wrong in the manner federal prosecutors have been allowed to litigate these cases as if they are in the “Wild West”.
Micheal Jones MD, New Orleans, LA
Prosecutors are able to easily appeal to the emotions of the jury all over the country where there is an ongoing opioid crisis such that it is estimated that at least 1 in every 4 individuals know of a person who has died of an overdose.
3
No other country criminalizes physician behavior like the federal prosecutors have done in the US. This is especially the case as these prosecutions are all based on a whim with an “expert” opinion rendered by a hired government expert and orchestrated by a new generation of overzealous and unchecked federal prosecutors pointing fingers at wealthy doctors as greedy drug pushers and fraudsters.
Walter Wrenn MD
Doctors are just a ‘sitting duck’ for these federal prosecutors who raid medical offices and unlike the career drug pusher on the streets who gets caught and charged with one or two counts, federal prosecutors pile up count after count because doctors are required to keep records and those records are used against them in these out of control prosecutions against physicians.
This case addresses an impermissible invasion of the federal government into state affairs where the practice of medicine is solely regulated by state medical boards.
Freddy Williams MD, Life (Died Colon Cancer)
Without any consultation and without any referral from state medical boards where the standard of practice of medicine and the definition of what is legitimate medical purpose is created and regulated, federal prosecutors have been pursuing indictment after indictment by capitalizing on the opioid crisis.
Lind Cheeks MD
It is not the federal government that regulates the practice of medicine and thus no federal prosecutor should be permitted to argue in court that a physician criminally violated the standard of care unless and until a criminal referral is generated by the state medical board where the accused physician practices.
Lesly Pompy MD., Anesthesiologist (facing life in prison)
Requiring prosecutors to first receive a criminal referral from the state regulatory agency prior to filing an indictment on scope of practice charges would eliminate the financial incentive by government hired experts who often tailor their testimony according to the hunch of federal prosecutors.
4
SUMMARY OF ARGUMENT
Dr. Xiulu Ruan was convicted of overprescribing controlled substances outside the usual course of medical practice and was sentenced tomore than 20 years in federal prison.
Xiulu Ruan MD., (Sentence 25 years)
Only the most prolific drug traffickers get these kind of sentences, and when they do, Rule 35 reductions will typically result in shortening their sentences.
Xiulu Ruan MD., Pain Med Physician
Both the conviction and the sentence is offensive to due process and basic tenets of a civilized society because both the conviction and the sentence is based on the whimsical notion of a prosecutor’s unfettered discretion and a paid expert opinion.
In Dr. Ruan’s case, as is the case in all scope of practice prosecutions, there is never a criminal referral by the regulatory state agency such as a state medical board. State medical boards regulate the practice of medicine as a neutral body and without a financial incentive.
XIULU RUAN, MD
However, most importantly, the state medical boards are charged with the task of setting the standard of care and what is legitimate and what is not legitimate medical purpose.
PHYSICIAN PAIN SPECIALIST OF ALABAMA
The fact that prosecutors have been able to bypass these state regulatory agencies in bringing about these “scope of practice” prosecutions speak volumes to unhinged prosecutorial overreach in our criminal justice system and impermissible intrusion of federal government into state affairs.
The practice of medicine is regulated by State Medical Boards in each state. In the United States, there is no federal regulation of the practice of medicine. “The power of a state to make reasonable provisions for determining the qualifications of those engaging in the practice of medicine, and punishing those who attempt to engage therein in defiance of such statutory
5
provisions, is not open to question.” Reetz v. People of State of Michigan, 188 U.S. 505, 505, 23 S. Ct. 390, 391, 47 L. Ed. 563 (1903).
While prescription of controlled substances is regulated through the issuance of registration numbers by a federal agency known as the Drug Enforcement Administration, (“DEA”), the manner and the propriety of dispensing controlled substances, i.e. the pain killers, are regulated by each state medical board.
CHART SHOWING ILLICIT NON PHARMACEUTICAL NON FDA APPROVE DRUG DEATH/ CATHLEEN LONDON MD 3RD YEAR LAW
State medical boards can penalize a physician by a number of disciplinary actions including but not limited to revocation of a medical license.
But in addition, and for eons, state medical boards have been deemed as the appropriate peer review body to deem when a physician’s conduct is outside the scope of acceptable practice and therefore dangerous to society.
GLINDA FINCHER (SICKLE CELL ADVOCATE)
In fact, litigation in this area has almost uniformly sided with state medical boards not just as the authoritative body on establishing standard of care and scope of practice but also as the authoritative body to deem when a licensee steps outside the established scope of practice. Rathle v. Grote, 584 F. Supp. 1128 (M.D. Ala. 1984); see also Steinbach v. Metzger, 63 F.2d 74, 76 (3d Cir. 1933) citing to Powell v. Pennsylvania, 127 U. S. 678, 683 (1888), holding that “a state may thus regulate the practice of medicine, using this word, in its most general sense, can no longer be questioned.”
GEORGE TENET MD DEA VICTIM
With federal prosecutors stepping into this arena to create criminal liability against physicians by relying on differences of opinion of hired experts, the United States has now become the only country in the world mass incarcerating physicians. However, mass incarcerating physicians is not because we are housing most of the
6
criminal doctors in the world, but rather because there is something fundamentally wrong with federal prosecutors stepping in as the ‘super’ experts to determine what is and what is not “outside the scope of professional practice” for a physician.
ARGUMENT
I. “WAR OF EXPERTS” CANNOT BE THE BASIS OF CRIMINAL LIABILITY IN “SCOPE OF PRACTICE” PROSECUTIONS
In an attempt to place the opioid crisis on the shoulders of physicians, federal prosecutors have been capitalizing on differences of opinion by paid experts in order to argue that criminal behavior exists. How many times do two judges have differences in opinion in rendering decisions that affect millions of lives?
Felix Brizuela DO, Neurologist
How many times do two prosecutors have differences of an opinion as to what is criminal behavior and what is not? But when prosecutors or judges have differences of an opinion, their behavior is not criminalized. But an accused physician’s behavior is criminalized instantly by the mere opinion of one prosecutor and the government hired expert.
If the government’s expert is more believable, more charismatic and more court room savvy, then no matter the facts, the accused physician becomes convicted especially with the playing field that is not leveled as prosecutors point fingers at the physician’s lifelong hard earned wealth as having been acquired fraudulently. Everyone, including the jury and the judge, falls for this drama. In nearly every one of these cases, prosecutors
7
argue that rich doctors writing prescriptions for controlled substances with patients who are paying cash cannot possibly be for a legitimate medical purpose. And in nearly every one of these cases, first the jury and then the judge fall for it.
RICHARD KAUL MD, ADVOCATE FIGHTER “DOCTOR WITH SPINE”
The Eleventh Circuit Court of Appeals has fallen the hardest for this drama as it has written the necessary element of mens rea out of existence in considering charges involving prescription fraud. 21 U.S.C. § 841(a)(1).
II. FEDERAL PROSECUTORS SHOULD BE REQUIRED TO HAVE A CRIMINAL REFERRAL FROM STATE MEDICAL BOARDS PRIOR TO INITIATING PROSECUTION FOR CHARGES RELATING TO “SCOPE OF PRACTICE”
Prosecutors should have the discretion to bring criminal prosecution against any individual irrespective of the profession of the individual. However, when the prosecution involves professional behavior that is regulated by a state agency, prosecutors should not have unfettered discretion without first receiving a criminal referral from a state medical board.
CATHLEEN LONDON MD, DEA TARGET, LAW ADVOCATE
This is because it is a state agency, not a federal agency, which regulates the practice of medicine. Only a state agency charged with the regulation of the practice of medicine can be qualified to deem what is dangerous and illegitimate for the profession it regulates—not a federal prosecutor who hires an expert to play out his hunch before the jury. Federal prosecutors deciding what is and is not “outside scope of
8
practice” is nothing other than prosecutorial overreach and exploitation of the practice of medicine. See United States v. Am. Med. Ass’n, 110 F.2d 703 (D.C. Cir. 1940) holding that “The practice of medicine in the District of Columbia is subject to licensing and regulation and may not lawfully be subjected to commercialization or exploitation.”
A collective consent and referral from the state’s medical board must be a prerequisite to each and every criminal prosecution against a physician who is accused of practicing medicine outside the scope of professional practice.
STEVE ARIENS RPH, PHARMACIST ADVOCATE
A federal prosecutor going out and hiring an expert to render an opinion that is tailored to his or her hunch is not fair process. But if the prosecutor has the green light of a state medical board that operates without financial incentives, then these criminal prosecutions against physicians will not offend due process as they do now.
RICHARD LAWHERN PHD, LAWHERN FILES ADVOCATE
It is not clear how the federal prosecutors lost their way, but it is certainly clear that they did so because they have, for so long, had unfettered discretion that has been repeatedly condoned by the courts. We are where we are today because it is not feasible to maintain integrity when there is such lack of accountability with very little to no redress for bringing these prosecutions for personal agenda. Lawyers are judged by other lawyers in state regulated agencies known as State Bars. Doctors should also be judged by a body of their own peers in state regulated agencies known as state Medical Boards.
9
III. DECISION IN RUAN SHOULD HAVE FULL RETROACTIVE EFFECT
For the past decade or more, physicians’ freedom has been hanging on the unfettered discretion of prosecutors and the opinion of their hired experts. In this endeavor, the prosecutors have scored big wins making United States the only country in the world that has the highest number of physicians behind bars.
STEVEN HENSON MD (NATURAL LIFE FEDERAL PRISON)
As of to date, we have physicians in federal prisons who are sentenced to 327 years, (US v. Mukerjee 4:04-cr-50044 in Eastern District of Michigan), life (US v. Henson 6:16-cr-10018 in District Court of Kansas), life
Paul Volkman MD
(US v. Webb 3:08-cr-00136 in Northern District of Florida), life (US v. Volkman 1:07-cr-00060 Southern District of Ohio), and countless more serving 20 years plus for prescribing controlled substances that a government hired expert believed was outside the scope of professional practice. Even the most prolific drug traffickers with known criminal enterprises that expand over several continents and in existence for decades do not get these stiff penalties. Actual trafficker of hard drugs serve less time (and leave prison with more money) than doctors who have spent their lives helping the sick.
Full retroactive effect should be considered by the Court due to the fact that criminal prosecutions initiated by federal prosecutors against physicians regarding charges involving scope of practice all are rooted in prosecutorial overreach violating fundamental rights of the accused to a fair trial. See Griffith v. Kentucky, 479 U.S. 314, 107 S. Ct. 708, 93 L. Ed. 2d 649 (1987), holding that failure to apply newly declared constitutional rule to criminal cases pending on direct review would violate basic norms of constitutional adjudication.
10
Going forward, all criminal prosecutions involving scope of practice charges should be required to have a criminal referral by the regulating state medical board which has no financial incentive to deem whether there has been behavior that is outside the scope of professional practice.
CONCLUSION
Federal prosecutions based on federal experts determining what is “outside the scope of professional practice” offends comity and should be eliminated. The only logical manner in which this can be done is by requiring a criminal referral to be made by state medical boards before federal prosecutors can initiate prosecution against physicians for charges relating to the practice of medicine.
DATED: December 27, 2021. Respectfully submitted,
/s/ Sebastian Ohanian
Sebastian Ohanian, Esq.
Counsel for Amicus Curiae Physicians Against Abuse
When I applied to Butler U for pharmacy school in 1996, after one year at a local extension of Indiana University – studying for a major in Chemistry
But what they did not tell you back then was around 1 out of 5 or 6 Freshman Pharmacy declared majors would make graduation. Getting in was EASY… getting to graduation was a BITCH… Back then, there was 82-84 pharmacy schools… today there is abt 142 schools and they are graduating some 14K-15K and those pharmacy grads from 1980 – abt 8,000 are now retiring… Doesn’t take a Math major to figure out that Pharmacy has a very serious – and growing – Pharmacist SURPLUS. Today, new grads are getting pay offer of abt $20/hr less than I was making when I retired in 2013 and unless the new grad agrees to be Pharmacy manager – may not even get FULL TIME. Today’s grads, many are coming out of school with a SIX FIGURE STUDENT LOANS. When I graduated from Butler U… I owed about what was 2-3 week’s pay, once I got licensed, which I was able to do in Kentucky by mid- July after graduation. Followed up getting my Indiana license in Sept or Oct.
The COVID-19 pandemic has created a work environment that has become both unsafe for the pts and the Rx dept staff. And many Pharmacists are starting to fight back… A local Walgreens a couple of months ago all three pharmacist WALKED OUT… similar things happened to local CVS’. Our small county of abt 80K population has THREE INDEPENDENTS and as far as I know … non of them missed a day being open their scheduled hours and Rx dept staffed.. Here is a hyperlink to help you find a independent pharmacy by zip code https://ncpa.org/pharmacy-locator
Back in the pre 90’s when independents dominated the market place, Pharmacists showed up FIRST PLACE on most respected profession surveys… the last survey I have seen Pharmacists are now down to FOURTH and now that the chains dominate the market place … probably headed for the end of the list along with used car salesmen and members of Congress. But those current surveys rank pharmacies by ownership… independents are always at the top ranking of the list by customers/pts.
Congressman Weber’s assistant has requested to hear from the residents of the great state of Texas. This is a golden opportunity for pain patients to bring the plight of untreated/under-treated pain patients in front of the Congressman. Specifically your pain story as well as any stories related to illicit fentanyl (i.e. whether you or someone you know has suffered from an illicit overdose) and suicide related to pain. In addition, the Congressman is interested in examining Texas state policy and its current is impact on pain patients (has Texas policy served as a detriment or interfered in your care).
The reason for this request is that I will be meeting with Congressman Weber’s office in the near future. I have been asked to gather the above requested information in preparation for this meeting. I am requesting that anyone who lives in Texas, who would like to participate, to please email their stories to me at: lrlonebear@ciaag.net by January 20, 2022.
I would like to reassure everyone that your information and any stories that are shared will be kept confidential and only used for the purposes of this meeting.
I am requesting that submissions are kept short and concise. While I recognize that each person has a unique story to tell, I am requesting that submissions are one page in length to include the following:
Your diagnosis
Are you currently receiving pain treatment?
Have you been force tapered/completely withdrawn from medications or tapered down to an ineffective dose?
Were you forced into using ineffective alternative/complimentary modalities?
Were you forced into taking medications or having procedures to justify receiving pain management?
Had any practitioner imply that the pain is “all in your head”?
Do you feel you have been harmed by Texas pain laws as they currently stand?
Thank you in advance for sharing your stories. Feel free to email me with any questions or comments.
In Turkey the metro stations allow dogs to sleep during the colder months. What an amazing gesture
“The moral test of a government is how it treats those who are at the dawn of life, the children; those who are in the twilight of life, the aged; and those who are in the shadow of life, the sick and the needy, and the handicapped.” – Hubert Humphrey
New Report Shows that 68% of Most Expensive Drugs in Medicare Are Imported, Implications for Savings and Safety
